Porcodine is a cough suppressant, expectorant and anti-nasal mucosal congestion, which is mainly used to treat severe dry cough and moderate pain in clinical practice.

The global Pholcodine market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Pholcodine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pholcodine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Pholcodine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Pill
Oral Solution

Segment by Application
Hospital
Pharmacy

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Yichang Renfu Pharmaceutical Co., Ltd.
Chongqing Oriental Pharmaceutical Co., Ltd.
Nanchang Lijian Pharmaceutical Co., Ltd.
Bright Future Pharmaceutical
Care
AFT Pharmaceuticals